Garen G. Bohlin - 06 May 2021 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
Director
Signature
/s/ Nancy Smith as Attorney-in-Fact for Garen Bohlin
Issuer symbol
KPTI
Transactions as of
06 May 2021
Net transactions value
+$31,280
Form type
4
Filing time
10 May 2021, 19:57:22 UTC
Next filing
24 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Purchase $31,280 +4,000 $7.82 4,000 06 May 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.